bluebird bio amends IPO

bluebird bio Inc., Cambridge, Mass. Business: Gene/Cell therapy, Hematology, Neurology Date announced: 6/4/13 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: J...